Stimulation of poliovirus RNA synthesis and virus maturation in a HeLa cell-free in vitro translation-RNA replication system by viral protein 3CDpro
© Franco et al; licensee BioMed Central Ltd. 2005
Received: 30 June 2005
Accepted: 21 November 2005
Published: 21 November 2005
Poliovirus protein 3CDpro possesses both proteinase and RNA binding activities, which are located in the 3Cpro domain of the protein. The RNA polymerase (3Dpol) domain of 3CDpro modulates these activities of the protein. We have recently shown that the level of 3CDpro in HeLa cell-free in vitro translation-RNA replication reactions is suboptimal for efficient virus production. However, the addition of either 3CDpro mRNA or of purified 3CDpro protein to in vitro reactions, programmed with viral RNA, results in a 100-fold increase in virus yield. Mutational analyses of 3CDpro indicated that RNA binding by the 3Cpro domain and the integrity of interface I in the 3Dpol domain of the protein are both required for function. The aim of these studies was to determine the exact step or steps at which 3CDpro enhances virus yield and to determine the mechanism by which this occurs. Our results suggest that the addition of extra 3CDpro to in vitro translation RNA-replication reactions results in a mild enhancement of both minus and plus strand RNA synthesis. By examining the viral particles formed in the in vitro reactions on sucrose gradients we determined that 3CDpro has only a slight stimulating effect on the synthesis of capsid precursors but it strikingly enhances the maturation of virus particles. Both the stimulation of RNA synthesis and the maturation of the virus particles are dependent on the presence of an intact RNA binding site within the 3Cpro domain of 3CDpro. In addition, the integrity of interface I in the 3Dpol domain of 3CDpro is required for efficient production of mature virus. Surprisingly, plus strand RNA synthesis and virus production in in vitro reactions, programmed with full-length transcript RNA, are not enhanced by the addition of extra 3CDpro. Our results indicate that the stimulation of RNA synthesis and virus maturation by 3CDpro in vitro is dependent on the presence of a VPg-linked RNA template.
The HeLa cell-free in vitro translation-RNA replication system  offers a novel and useful method for studies of the individual steps in the life cycle of poliovirus. These processes include the translation of the input RNA, processing of the polyprotein, formation of membranous replication complexes, uridylylation of the terminal protein VPg, synthesis of minus and plus strand RNA, and encapsidation of the progeny RNA genomes to yield authentic progeny virions [1–4]. Although these processes occurring in vitro represent, in large part, what happens in virus-infected cells, there are also differences between virus production in vivo and in vitro. In the in vitro system a large amount of viral RNA (~1 × 1011 RNA molecules) has to be used, as template for translation and replication, in order to obtain infectious viral particles and the yield of virus is still relatively low. This has been attributed to insufficient concentrations of viral proteins for RNA synthesis or encapsidation, to differences in membranous structures or the instability of viral particles in vitro [3, 5]. With the large amount of input RNA the level of translation in vitro is relatively high from the beginning of incubation and hence complementation between viral proteins is more efficient than in vivo [6, 7]. We have recently observed that in vitro translation-RNA replication reactions, programmed with viral RNA, contain suboptimal concentrations of the important viral precursor protein 3CDpro for efficient virus production. By supplying the in vitro reactions at the beginning of incubation either with 3CDpro mRNA or purified 3CDpro protein the virus yield could be enhanced 100 fold [8, 9]. Our results also indicated that both the 3Cpro proteinase and 3Dpol polymerase domains of the protein are required for its enhancing activity.
The viral proteins most directly involved in RNA replication include protein 3AB, the precursor of 3A, which is a small membrane binding and RNA binding protein, the terminal protein VPg, RNA polymerase 3Dpol and proteinase 3Cpro/3CDpro. As a proteinase 3CDpro is responsible for the processing of the capsid precursor  but it also has very important functions as an RNA binding protein [17–21]. It forms complexes with the 5' cloverleaf structure in PV RNA either in the presence of cellular protein PCBP2 [18, 22] or viral protein 3AB . The interaction between PCBP2, 3CDpro and the cloverleaf has been proposed to mediate the switch from translation to RNA replication  and the circularization of PV RNA through interaction with poly(A) binding protein bound to the poly(A) tail of the genome . In addition, 3CDpro binds to the cre(2C) element [20, 21], and to the 3'NTR in a complex with 3AB . Polypeptide 3CDpro is also a precursor of proteinase 3Cpro and RNA polymerase 3Dpol. The 3Cpro domain of the polypetide contains both the proteinase active site and the primary RNA binding domain [25, 26]. The function of the 3Dpol domain appears to be to modulate these activities of the protein [27, 28] and it also contains RNA binding determinants . By itself 3Dpol is the RNA dependent RNA polymerase, which possesses two distinct synthetic activities. It elongates oligonucleotide primers on a suitable template  and it links UMP to the hydroxyl group of a tyrosine in the terminal protein VPg . The 3Dpol polypeptide possesses a structure similar to other nucleic acid polymerases of a right hand with palm, thumb and finger subdomains . Interaction between polymerase molecules along interface I results in a head to tail oligomerization of the protein, which is important for its biological functions .
The aim of these studies was to determine how the addition of extra 3CDpro protein to in vitro translation RNA-replication reactions, programmed with viral RNA, stimulates virus synthesis by 100 fold. In the presence of extra 3CDpro we have observed a mild stimulation of both minus and plus strand RNA synthesis. The primary effect of 3CDpro, however, is the enhancement of virus maturation resulting in a striking increase in the specific infectivity of the virus particles produced. Both of these processes are dependent on the RNA binding activity of the protein in the 3Cpro domain. Mutational analysis of 3CDpro suggests that the formation of 155S mature virions also requires an intact interface I in the 3Dpol domain of the protein. Interestingly, plus strand RNA synthesis and virus production in translation RNA-replication reactions, programmed with PV transcript RNA, are not stimulated by 3CDpro.
Effect of 3CDpro(3CproH40A) on viral RNA synthesis in in vitro translation-RNA replication reactions
Protein 3CDpro is the precursor of both proteinase 3Cpro and polymerase 3Dpol. The 3Cpro domain contains both the proteinase and the RNA binding site [25, 26]. While the primary RNA binding determinant of 3CDpro lies in 3Cpro, lower affinity binding determinants are located in the 3Dpol domain [27, 28]. We have recently shown that a mutation (3CproR84A/I86A) in the RNA binding domain of 3CDpro abolishes that ability of the protein to stimulate virus production in the in vitro system . To examine the effect of these mutations on RNA synthesis we have carried out translation-RNA replication reactions in the presence 3CDpro(3CproR84S/I86A) mRNA. As shown in Fig. 2A, the mutation totally abolished the stimulatory activity of 3CDpro(3CproH40A) in RNA synthesis suggesting that RNA binding is required for participation of the extra 3CDpro(3CproH40A) in genome replication.
Our previous results indicated that the 3Dpol domain of 3CDpro is also required for the ability of 3CDpro to stimulate virus synthesis in the in vitro system . This conclusion was based on the observation that two groups of mutations R455A/R456A  and D339A/S341A/D349A  in the 3Dpol domain of the protein abolished the enhancement of virus yield in the in vitro system . These complementary mutations in the thumb and palm subdomains of the protein, respectively, are located at interface I of the 3Dpol protein structure and have been found to disrupt the oligomerization of the polypeptide [32, 33]. Previous studies have indicated that oligomeric forms of the 3Dpol polypeptide are required for enzyme function . To determine the effect of 3CDpro(3CproH40G, 3DpolR455A/R456A) on RNA synthesis we added the purified mutant protein to translation RNA-replication reactions. This mutant protein exhibited a 2-fold stimulation in RNA synthesis, only slightly lower than what is obtained with 3CDpro(3CproH40A) (Fig. 2A). This result indicates that 3Dpol residues R455 and R456 are not important for the stimulatory activity of 3CDpro in RNA synthesis. The effect of the other mutant 3CDpro protein (3DpolD339A/S341A/D349A) on RNA synthesis was not analyzed.
3CDpro(3CproH40A) has a small stimulatory effect on both minus and plus strand RNA synthesis
To examine the effect of 3CDpro on plus strand RNA synthesis we translated the viral RNA for 4 hr in the absence or presence of extra 3CDpro(3CproH40A). The initiation complexes  were isolated by centrifugation and resuspended in reaction mixtures lacking viral RNA but containing [α-32P]CTP. After 1 hr of incubation the RNA products were applied to a nondenaturing agarose gel together with a [α-32P]-labeled full-length poliovirus RNA transcript as a size marker (Fig. 2B, lane 1). The yield of plus strand RNA product obtained from these reactions was equally enhanced by the addition of extra 3CDpro(3CproH40A) or by mutant 3CDpro(3CproH40G, 3DpolR455A/R456A) protein (Fig. 2B, compare lane 4 with lanes 2 and 5). No product was formed in the absence of a viral RNA template (Figs. 2B and 2C, lane 3). When 3CDpro mRNA, containing the R84S/I86A mutations in the RNA binding domain of 3Cpro, was cotranslated with the input viral RNA no stimulation of plus strand RNA synthesis was observed (Fig. 2C, compare lanes 2 and 4). These results indicate that RNA binding by the extra 3CDpro(3CproH40A) is required for the stimulation of plus strand RNA synthesis but mutation R455A/R456A in the 3Dpol domain of the protein is not important for this process.
The addition of 3CDpro(3CproH40A) and 3Cpro(C147G) together totally blocks RNA synthesis in translation-RNA replication reactions
We have recently shown that purified 3Cpro(C147G) protein, containing a proteinase active site mutation, when added alone to in vitro translation-RNA replication reactions, has no effect on virus yield. However, when included in reactions along with extra 3CDpro(3CproH40A) the production of virus is reduced about 1 × 104 fold . To determine whether the inhibitory effect of 3Cpro(C147G) is at the level of RNA synthesis, we have examined the time course of RNA synthesis in the presence of both proteins by measuring the amount of [α-35S]UMP incorporated into polymer. As shown in Fig. 3A, the effect of these proteins on RNA synthesis fully parallels their effect on virus synthesis . 3CDpro(3CproH40A) stimulates RNA synthesis up to 3-fold while 3Cpro(C147G) alone exhibits no significant enhancement of the RNA yield. When the two proteins are added together there is essentially no increase in the total amount of RNA produced over a period of 16 hours. Control reactions, lacking a viral RNA template exhibited very little, if any, incorporation of label into a polymeric product (Fig. 3A). All other samples showed some incorporation of label into polymer, over what is measured in the absence of viral RNA (Fig. 3A). This is most likely a result of end labeling of the input viral RNA by newly translated 3Dpol or priming by traces of degraded RNA.
To determine whether 3Cpro(C147G) inhibits plus or minus strand RNA synthesis we labeled with [α-32P]CMP the RNA products formed in preinintiation replication complexes during a 1 hr incubation period, as described above. The samples were analyzed on a nondenaturing agarose gel and as a size marker we used [α-32P]CMP-labeled RNA products made in CRCs (Figs. 3B and 3C, lane 1). Two kinds of products were visible on the gel, the newly made single stranded RNA (ssRNA) and the double stranded replicative intermediate (RF). As shown on Fig. 3B, 3Cpro(C147G) alone has very little, if any, effect on the yield of either of the 2 kinds of RNA products (Fig. 3B and 3C, compare lanes 2 and 3). In the presence of both 3Cpro(C147G) and 3CDpro(3CproH40A), however, the synthesis of both products is completely inhibited (Figs. 3B and 3C, compare lane 4 and lane 5).
3CDpro(3CproH40A) has a small stimulating effect on the early steps of viral particle assembly
To confirm the presence of uncleaved VP0 in the 5S and 14S peak fractions of the gradient derived from reactions supplemented with extra 3CDpro(3CproH40A), we used Western blot analyses with anti VP2 polyclonal antibody (Fig. 4C). As expected, only VP0 and no VP2 could be detected in the 5S and 14S peak fractions containing these small capsid precursors (Fig. 4C).
3CDpro(3CproH40A) has a small stimulatory effect on the late stages of particle assembly
In the next set of experiments we examined the effect of 3CDpro(3CproH40A) on the formation of 80S (empty capsids) and 155S particles (provirion and mature virus). As we discussed before, the role of the 80S particle in viral assembly is unclear. The experimental evidence available at this time favors the hypothesis that empty capsids are dead-end products rather than true intermediates of particle assembly [12, 13]. The particle thought to be the direct precursor of the mature virus is the provirion, a structure containing 60 copies of VP0, VP1 and VP3 and the viral RNA . The difference between provirions and mature virus is that in the latter the particle is stabilized by the cleavage of VP0 to VP2 and VP4.
3CDpro(3CproH40A) strongly enhances the production of mature viral particles
As we discussed above, the extra 3CDpro(3CproH40A) added to translation-RNA replication reactions has a relatively small stimulating effect both on RNA synthesis and on the incorporation of [35S]-methionine into capsid precursors, empty capsids or particles sedimenting at 155S. These results are difficult to reconcile with the 100-fold increase in infectious virus observed in translation RNA-replication reactions that are supplemented with extra 3CDpro(3CproH40A) [8, 9]. Taken together these findings suggested the possibility that the presence of extra 3CDpro(3CproH40A) enhances the specific infectivity of the virus particles produced, that is, it enhances the conversion of provirions to virions. To test this hypothesis we measured the yield of infectious virions in the peak fractions sedimenting at 155S in sucrose gradients derived from in vitro reactions incubated with or without extra 3CDpro(3CproH40A). As shown on Fig. 5C, reactions to which extra 3CDpro(3CproH40A) protein was added yielded 155S peaks containing 100 fold higher plaque forming units than reactions that were not supplemented with the protein. Interestingly, neither mutant 3CDpro proteins (3CproR84S/I86A or 3CproH40G, 3DpolR455A/R456A) enhanced the virus yield in the 155S peak of the gradient (Fig. 5), an observation suggesting that both domains of the protein are required for this function. In a parallel experiment we have estimated the total number of viral particles in the 155S peak of the gradient by electron microscopy. We observed about 3-fold increase in viral particles when 3CDpro(3CproH40A) was present in the translation-RNA replication reactions (data not shown).
To obtain further proof that the extra 3CDpro(3CproH40A) enhances the specific infectivity of the virus particles we used SDS treatment of the reaction products prior to sucrose gradient analysis. The incorporation of [35S]-methionine into particles sedimenting at 80S and 155S was determined in reactions treated with SDS. It has been previously demonstrated that only mature virions but not provirions are stable in SDS . As shown on Fig. 6A, there was no increase in 80S particles in SDS-treated samples that contained extra 3CDpro(3CproH40A) (Fig. 6A) suggesting that the sample did not contain significant amounts of provirions. On the other hand, the 80S empty capsid peak, obtained from reactions with no extra 3CDpro(3CproH40A) or with 3CDpro(3CproH40G, 3DpolR455A/R456A) mutant protein, increased by about 4 fold as a result of SDS treatment. Interestingly, most of the extra label that appear in this 80S peak following SDS treatment is not derived from the 155S peak, presumably by the dissociation of provirions into 80S empty capsids and RNA (Fig. 6A). This suggested to us the possibility that in reactions lacking extra 3CDpro(3CproH40A) some of the 80S particles aggregated and pelleted in the gradient. To test this possibility we recovered and analyzed the pellets from the gradients. We observed that the amount of [35S]-label in the pellet, derived from reactions with no extra 3CDpro, was 10-fold higher than in pellets of reactions lacking the extra protein (data not shown). A Western blot analysis of the particles in the pellets indicated the presence of VP0 but no VP2 (data not shown).
3CDpro(3CproH40A) does not stimulate RNA synthesis or virus production in translation RNA-replication reactions programmed with transcript RNA
Transfection of full-length transcript RNAs of poliovirus, made by T7 RNA polymerase, into HeLa cells initiate a complete replication cycle although the yield of virus is only 5% of that obtained in transfections with virion RNA . In the in vitro translation-RNA replication system the yield of virus with transcript RNAs is also significantly reduced to about 1% of what is obtained when the reactions are supplemented with viral RNA [39, 40]. This has been attributed to the presence of two extra GMPs at the 5'-end of the transcript RNAs (pppGpGpUpU...), which are removed during replication to yield authentic viral RNA (VPg-pUpU...) . Previous studies have demonstrated that the two GMPs at the 5' end of transcript RNAs do not interfere with minus strand RNA synthesis but greatly reduce the initiation of plus strand RNA synthesis in the in vitro system. Removal of the extra nucleotides with a cis-active hammerhead ribozyme resulted in templates that have regained most of their ability to support efficient plus strand RNA synthesis in the translation-RNA replication system .
Previous studies have demonstrated that in the in vitro translation-RNA replication system the amount of plus strand RNA product obtained from PV ribozyme-treated transcript RNA or viral RNA is about 100-fold higher than what is produced in reactions with ribozyme-deficient transcript RNAs . To examine whether the lack of enhancement of virus production by 3CDpro(3CproH40A) in our reactions using a ribozyme-deficient transcript RNA is due to a defect in stimulating RNA synthesis we have measured the yield of plus strand RNA. Translation-RNA replication reactions were incubated for 4 hr at 34°C, the initiation complexes were collected by centrifugation and resuspended in reactions lacking transcript RNA. The RNA products were labeled with [α-32P]CTP for 1 hr and the products were applied to a nondenaturing gel. As shown in Fig. 8B, the presence of extra 3CDpro(3CproH40A) in such reactions has no stimulatory effect on plus strand RNA synthesis (compare lane 2 with lane 3). As a size marker for plus strand RNA we have included the [α-32P]-labeled full-length PV ssRNA product made in CRCs (Fig. 8B, lane 1). The same results were obtained when RNA synthesis was measured with ribozyme-treated transcript RNA as template for translation-RNA replication (Fig. 8C, compare lane 2 with lane 3). It should be noted that the addition of extra 3CDpro(3CproH40A) to translation reactions of transcript PV RNA had no effect either on the efficiency of translation or the processing of the polyprotein (data not shown).
The lethal R84S/I86A mutation in the 3Cpro domain of 3CDpro cannot be complemented in vitro by wt 3CDpro
Mutation R84S/I86A in the RNA binding domain of 3Cpro cannot be complemented in vitro with wt 3CDpro.a
Infectivity (pfu/μg transcript RNA)
PVM(3CproR84S/I86A) Tr RNA
PVM(3CproR84S/I86A) Tr RNA + 1.4 μg/ml 3CDpro mRNA
PVM (3CproR84S/I86A) Tr RNA + 400 ng/ml 3CDpro protein
We have previously shown that the level of active 3CDpro in in vitro translation-RNA replication reactions, programmed with viral RNA, is suboptimal for efficient virus synthesis and that the addition of extra 3CDpro compensates to some extent for this deficiency [8, 9] but the reason for this phenomenon remained unsolved. The results presented in this paper indicate that the stimulatory effect of 3CDpro is both at the level of RNA synthesis and of virus maturation. Since translation, replication, and encapsidation are coupled processes during the growth of poliovirus [13, 42, 43] one might conclude that the increase in the yield of mature virions simply reflects the stimulation of RNA synthesis. However, although this might be true to some extent, our results indicate that 3CDpro(3CproH40A) exerts its enhancing activity at two distinct stages of the viral growth cycle. This conclusion is supported by three lines of evidence: (1) plus strand RNA synthesis is stimulated by 3CDpro(3CproH40A) about 3-fold but the yield of progeny virus increases 100 fold; (2) although 3CDpro(3CproH40G, 3DpolR455A/R456A), containing mutations at interface I in the 3Dpol domain of the protein, enhance RNA synthesis nearly as efficiently as 3CDpro(3CproH40A) it does not stimulate the yield of mature virus; (3) only those reactions that contain extra 3CDpro(3CproH40A) yield a 155S peak in sucrose gradients with particles resistant to SDS treatment.
Our results with the in vitro translation-RNA replication system do not define the precise role of the extra 3CDpro in stimulating RNA synthesis. The evidence available thus far indicates that in the presence of extra 3CDpro(3CproH40A) (1) minus and plus strand RNA synthesis are stimulated 2- and 3-fold, respectively; (2) the RNA binding sequences (R84/I86) in the 3Cpro domain of the polyprotein are required for the stimulation; (3) the integrity of interface I in the 3Dpol domain of the polyprotein is not important. Whether plus strand RNA synthesis itself is stimulated by the presence of extra 3CDpro or the amount of plus strands increases simply as a result of more minus strands remains to be determined. The fact that the RNA binding domain of the protein in 3Cpro is involved in stimulating RNA synthesis suggests that the extra 3CDpro forms a functional ribonucleoprotein complex (RNP) with an RNA sequence or structure in the viral genome. Poliovirus RNA contains at least 3 different cis-acting elements that are involved in RNA replication. All of these bind 3CDpro, the 5' cloverleaf [17, 18, 22], the cre(2C) element [20, 21] and the 3'NTR . From these 3 structures only the 5' cloverleaf [18, 19, 22, 44] and the cre(2C) stem loop structure [20, 21, 45] have been shown so far to form a biological relevant RNP complex with 3CDpro. The cloverleaf has been shown to be required for minus strand, and possibly also for plus strand RNA synthesis [17, 46]. The RNP complexes of the cloverleaf with 3CDpro, which also include either PCBP2 or 3AB, are also required for both minus and plus strand RNA synthesis [17, 19, 44, 47].
The other important cis-replicating element involved in poliovirus RNA replication, which also binds 3CDpro, is the cre(2C) hairpin [20, 21, 45]. A conserved AAA sequence in this RNA element serves as template for the synthesis of VPgpU(pU), the primer for RNA synthesis [20, 45]. The role of 3CDpro in this reaction is believed to be to enhance the binding of the polymerase/VPg complex to the cre(2C) element [20, 21, 45]. The question whether the VPgpU(pU) made in this reaction is used exclusively for plus strand RNA synthesis  or also for minus strand synthesis remains controversial. The RNA binding sequences (R84/I86) of 3Cpro in 3CDpro but not amino acids R455/R456 at interface I in the 3Dpol domain are essential for the protein's stimulatory activity both in VPg-uridylylation in vitro [20, 33] and in the stimulation of RNA synthesis in the translation-RNA replication system. Taken together these results are consistent with a possible role of either the 3CDpro/cloverleaf or the 3CDpro/cre(2C) interactions in the stimulatory activity of the protein in RNA synthesis, which is dependent on the RNA binding activity of the 3Cpro domain.
We have previously reported the interesting observation that the addition of purified protein 3Cpro(C147G) along with 3CDpro(3CproH40A) to translation-RNA replication reactions reduces the virus yield about ten thousand fold . In this paper we show that at least one of the reasons for the nearly total inhibition of virus production under these conditions is that there is a striking inhibition of both minus and plus strand RNA synthesis. One possible explanation of our in vitro results is that the two proteins form a complex, through intermolecular contacts in 3Cpro , which is inactive and either cannot bind to the RNA or the RNP complex is nonfunctional. Alternatively, the two proteins interact with the same RNA sequence or structure but only the 3CDpro/RNA complex is functional in RNA synthesis. Of the three cis-replicating elements contained within PV RNA both the cloverleaf and the cre(2C) element have been shown to form RNP complexes with either 3CDpro or 3Cpro [17, 21]. In case of the cloverleaf only the 3CDpro/RNP complex is functional in replication but both protein-RNA complexes stimulate VPg-uridylylation on the cre(2C) RNA element . These results suggest that the RNA sequence or structure involved in the stimulatory activity of 3CDpro in RNA synthesis in the in vitro system is the cloverleaf rather than the cre(2C) element.
As we discussed above, the second step in the life cycle of PV where the extra 3CDpro(3CproH40A) appears to exert its stimulatory effect in vitro is during the late stages of particle assembly, and in particular during virus maturation. Although the addition of extra 3CDpro(3CproH40A) leads to a slight increase in the amount of small capsid precursors, the primary effect of the protein is at the step during which provirions are converted to mature viral particles. Although the mechanism of maturation cleavage is not fully understood it has been well established that the process is dependent on the presence of viral RNA [reviewed in ]. The exact function of 3CDpro(3CproH40A) in virus maturation is not yet known. Interestingly, both the RNA binding sequences in 3Cpro and the integrity of interface I in the 3Dpol domain of 3CDpro are required for function but the proteolytic activity of the protein is dispensable. The fact that the RNA binding domain of 3Cpro is essential for function indicates that 3CDpro has to interact with a sequence or structure in the viral RNA. The observation that the integrity of interface I in the 3Dpol domain of the protein is also required for this process is more difficult to explain. Although the oligomerization of 3CDpro along interface I in 3Dpol has not yet been directly tested, recent structural studies of the RNA polymerase suggest that oligomerization of the protein along interface I is possible . In addition, recent studies of genetically modified 3CDpro polypeptides in RNA replication strongly support a role of 3CDpro/3CDpro complexes, mediated by 3Dpol domain contacts . Whether the function of interface I in the 3Dpol domain of 3CDpro in virus maturation is related to the RNA binding properties of the protein remains to be determined. Our recent in vitro studies indicate that mutation 3DpolR455A/R456A in the context of 3CDpro alter the RNA binding properties of the protein such that twice as much of the mutant protein is required for optimal binding to a cre(2C) RNA probe than of the wt protein [Pathak and Cameron, unpublished results]. Oligomerization of 3CDpro might also be aided by intermolecular contacts between the 3Cpro domains of two molecules . However, it should be noted that no interaction can be detected between 3Cpro molecules in chemical cross-linking experiments in vitro and only very poor, if any, complex formation can be observed between either 3Cpro/3Cpro or 3CDpro/3CDpro molecules in the yeast two hybrid system .
On the basis of these observations we propose 2 possible models for efficient virus maturation in the in vitro translation-RNA replication reactions supplemented with extra 3CDpro(3CproH40A). According to the first model 3CDpro(3CproH40A) interacts with the progeny plus strand RNA, possibly at the cloverleaf, and causes an important conformational change. This step requires the RNA binding activity of the 3Cpro domain of the protein but binding might also be enhanced by the oligomerization of the polypeptide along interface I in the 3Dpol domain. Subsequently the RNA interacts either with the pentamers or the empty capsid and it is encapsidated, yielding a provirion while 3CDpro(3CproH40A) leaves the complex. The correct conformation of the RNA inside the provirions affects the shape of the capsid such that now the cleavage of the VP0s is favored to complete maturation. The second model is similar to the first one except that now 3CDpro(3CproH40A) itself is encapsidated, bound to the progeny RNA. This keeps the RNA in the correct conformation inside the capsid so that the maturation cleavage of VP0 can occur. The second model is supported by previous studies by Newman and Brown who observed that 3CDpro, 3Dpol and 2CATPase proteins were contained within isolated poliovirus and foot-and-mouth disease virus particles . In this context one should note that the scissile bond in VP0 is located on the rim of a trefoil-shaped depression on the capsid's inner surface, which has the potential of binding either RNA or other macromolecules . However, we did not detect any 3CDpro in our 155S peak derived from reactions with extra 3CDpro(3CproH40A) using Western blot analysis with either anti 3Cpro or anti 3Dpol antibodies [data not shown]. In any case, the suboptimal concentration of functional 3CDpro in translation RNA-replication reactions might lead to progeny RNA molecules lacking the proper conformation for encapsidation and efficient virus maturation.
One of the factors that limits the use of the in vitro translation-RNA replication system in studies of RNA replication is the poor function of transcript RNAs as templates in the reaction, lowering the yield of progeny plus strand RNA and of virus to about 1% of what is obtained with virion RNA [39, 40]. This has been attributed to the presence of two GMP molecules at the 5' end of RNAs transcribed from a T7 promoter . We hoped that by supplying the inefficient in vitro reactions with an excess of 3CDpro(3CproH40A) the synthesis of plus strands, and consequently the production of mature virus could be enhanced. To our surprise, this does not happen. The simplest explanation of these observations is that the level of endogenous 3CDpro is sufficient for the synthesis of the low level of plus strand RNA that is produced in the system. Therefore supplying the reactions with extra 3CDpro(3CproH40A) would have no stimulatory effect. However, this explanation does not account for the fact that virus synthesis is not stimulated by 3CDpro(3CproH40A) in reactions containing ribozyme-treated transcript RNAs. The yield of virus in such reactions is 50-fold higher than in samples in which ribozyme-deficient transcripts were used as template for translation and RNA replication. The only known difference between viral RNA and ribozyme-treated transcript RNA is the lack of VPg in the latter structure. Therefore our results indicate that the presence of VPg at the 5' end of the input viral RNA [53, 54] is an important determinant of the ability of 3CDpro(3CproH40A) to stimulate RNA synthesis and production of viable virions. Interestingly, the addition of extra 3CDpro(3CproH40A) at the beginning of incubation does not stimulate these processes once the newly made VPg-linked viral RNAs are used as templates for replication and packaging. This suggests that at least one of the stimulatory functions of 3CDpro is required at the time RNA synthesis is initiated from the input VPg-linked RNA template. Our results also suggest that either directly or indirectly the presence of VPg on the input RNA template is important for the stimulation by 3CDpro(3CproH40A) of the encapsidation of the newly made viral RNAs. The involvement of VPg in encapsidation has been previously proposed by Reuer et al.  who observed that some lethal VPg mutations still permit near normal minus and plus strand RNA synthesis in vivo.
It has been known for some time that complementation between viral proteins is more efficient in the in vitro translation-RNA replication system than in vivo. This is most likely due to relatively large local concentrations of viral proteins that are translated from the input viral RNA template used in the in vitro reactions. The results described in this paper show that at least two functions of 3CDpro are complementable in vitro. One is in RNA synthesis and the other in virus maturation and both of these processes require the RNA binding sequence of the 3Cpro domain. In an attempt to determine whether the RNA binding function of 3CDpro(3CproH40A) is required for additional processes in viral growth we tried to complement the lethal 3CproR84S/I86A mutation in the PV genome in vitro either by the addition of 3CDpro(3CproH40A) protein or wt 3CDpro mRNA. We obtained no virus suggesting that one or more of the RNA binding functions of 3CDpro, distinct from the ones described by us, cannot be complemented in vitro. An alternate explanation of the observation is that 3CDpro cannot substitute for 3Cpro in one or more of its functions.
The results presented in this paper have yielded insights into the steps of the viral life cycle in which the extra 3CDpro(3CproH40A) exerts its stimulatory function in the translation-RNA replication system. Our results also suggest a new role for protein 3CDpro in the life cycle of poliovirus, in virus maturation, which is dependent on the integrity of interface I in the 3Dpol domain of the protein. In addition, we have shown that a VPg-linked PV RNA linked template and the 3Cpro domain of the 3CDpro(3CproH40A) polypeptide are required both for the stimulation of RNA synthesis and for virus maturation. However, the exact mechanism of stimulation by 3CDpro both during RNA synthesis and particle assembly remains to be determined.
Materials and methods
Cells and viruses
HeLa R19 cell monolayers and suspension cultures of HeLa S3 cells were maintained in DMEM supplemented with 5% fetal bovine calf serum. Poliovirus was amplified on HeLa R19 cells as described before. The infectivity of virus stocks was determined by plaque assays on HeLa R19 monolayers, as described before .
Preparation of poliovirus RNA
Virus stocks were grown and purified by CsCl gradient centrifugation . Viral RNA was isolated from the purified virus stocks with a 1:1 mixture of phenol and chloroform. The purified RNA was precipitated by the addition of 2 volumes of ethanol.
Preparation of HeLa cytoplamic extracts
HeLa S10 extracts were prepared as previously described [1, 56] except for the following modifications: (1) packed cells from 2 liters of HeLa S10 were resuspended in 1.0 volumes (relative to packed cell volume) of hypotonic buffer; (2) the final extracts were not dialyzed.
Translation-RNA replication reactions with HeLa cell-free extracts and plaque assays
Viral RNA was translated at 34°C in the presence of unlabeled methionine, 200 μM each CTP, GTP, UTP, and 1 mM ATP in a total volume of 25 μl [1, 5]. After incubation for 12–15 hr the samples were diluted with phosphate-buffered saline and were added to HeLa cell monolayers. Virus titers were determined by plaque assay, as described previously [1, 55].
Filter binding assays for measurement of total RNA synthesis
Method I. Translation-RNA replication reactions (125 μl) were incubated at 34°C in the presence of 62.5 μC of [α-35S]CTP (ICN, 600Ci/mmole) but lacking unlabeled CTP. At the indicated times samples were taken and the reactions were stopped by the addition of SDS to a final concentration of 0.5%. The samples were extracted with phenol-chloroform and the RNA was precipitated with ethanol. The pellets were resuspended in 10 mM Tris pH 7.5, 1 mM EDTA and were loaded on a DEAE-81 filter papers (Whatman). The filters were dried and subsequently washed three times with 5% Na2HPO4, once with water and once with 70% ethanol, as described before . Method II. Each translation-RNAreplication reaction was incubated separately at 34°C. At the indicated times (2, 4, 6, 8, and 16 hr) 12.5 μC of [α-35S]CTP was added and incubation was continued for 1 hr. The samples were treated and analyzed as described in Method I.
Preinitiation RNA replication complexes
Preinitiation RNA replication complexes were prepared as described previously  except for some minor modifications. Translation-RNA replication reactions, lacking initiation factors, were incubated for 4 hr at 34°C either in the presence or absence of 2 mM guanidine HCl. The complexes were isolated by centrifugation, resuspended in 50 μl HeLa S10 translation/replication reaction mixture without viral RNA, and incubated for 11 hr at 34°C.
Plus and minus strand RNA synthesis
Plus and minus strand RNA synthesis were determined as described previously . Translation RNA replication reactions, programmed with viral RNA, were incubated for 4 hr in the presence of 2 mM guanidine HCl. The preinitiation replication complexes were resuspended in translation-RNA replication reactions lacking viral RNA in the presence of [α-32P]CTP. The reactions were incubated at 34°C for 1 hr, the labeled RNAs were separated by native agarose gel electrophoresis, and the products were visualized by autoradiography. The reaction products were quantitated with a Phosphorimager (Molecular Dynamics Storm 800) by measuring the amount the amount of [α-32P]CMP incorporated into RNA.
Alternatively, plus strand RNA synthesis was measured in translation-RNA replication reactions that were incubated for 4 hr at 34°C, in the absence of guanidine HCl, and the initiation complexes were isolated by centrifugation. They were resuspended in translation-RNA replication reactions lacking viral RNA but supplemented with [α-32P]CTP. The samples were incubated for 1 hr at 34°C and the RNA products were separated on a native agarose gel. The products were visualized by autoradiography.
In vitro transcription and translation
All plasmids were linearized with EcoR I prior to transcription by T7 RNA polymerase. The transcript RNAs were purified by phenol/chloroform extraction and ethanol precipitation. Translation reactions (25 μl) containing 8.8 μC of Trans [35S]Label (ICN Biochemicals) were incubated for 4 hours at 34°C . The samples were analyzed by electrophoresis on sodium deodecyl sulfate-12% polyacrylamide gels, followed by autoradiography.
RNA synthesis with crude replication complexes
Crude replication complexes (CRCs) were prepared by a method similar to what has been described before . HeLa cell monolayers (15 cm) were infected with PVM at a multiplicity of infection of 500. After 6 hr incubation at 37°C the cells were resuspendend in hypotonic buffer  and were lysed with a Dounce homogenizer. Cell debris and nuclei were removed by centrifugation for 20 min at 33,000 × g. The pellet was subsequently resuspended in 1 ml of 10 mM Tris-HCl pH 8.0, 10 mM NaCl, and 15% glycerol. Aliquots were stored at -80°C.
RNA synthesis by CRCs was measured as described before . In vitro translation-RNA replication reactions were assembled in which the HeLa extracts were replaced by CRCs (20% by volume). The reaction contained 49% by volume of S10 buffer  and 25 μC of [α-32P]CTP.
Sucrose gradient centrifugation of viral particles
HeLa S10 translation-RNA replication reactions (25 μl) were incubated in the presence of 8.8 μC of [35S]TransLabel (ICN Biochemicals) for 12 hr at 34°C. The excess unincorporated label was removed by dialysis. The samples were introduced into a Slide-a-lyzer (Pierce Endogen) dialysis cassette with a M.Wt cut-off of 10 kD and were dialyzed several times against phosphate buffer at 4°C until essentially all the excess label was eliminated. After dialysis the samples were centrifuged at 14,000 × g to remove any precipitated material. The samples were diluted to 500 μl and were centrifuged in a 5–20% sucrose density gradient in phosphate buffered saline containing 0.01% bovine serum albumin in a SW41 rotor at 40,000 rpm at 4°C. To separate 80S empty capsids and 155S virus particles (provirions and virions) the gradients were centrifuged for 80 min . To identify 5S protomers and 14S pentamers the gradients were centrifuged for 15 hr. Fractions (0.5 ml) were collected from the bottom of the gradients and the radioactivity of each sample was determined by scintillation counting. In each sucrose gradient cetrifugation size markers were sedimented in parallel consisting of [35S]-labeled PV-infected HeLa cell extracts.
Western blot analysis
For the identification of the capsid proteins present in sucrose gradient fractions Western blot analysis was used . Samples were loaded on a SDS-polyacrylamide gel (12.5% acrylamide) and after separation the proteins were transferred to a nitrocellulose membrane (Protran; Schleicher&Schuell). The membrane was probed with a rabbit polyclonal antibody to PV capsid protein VP2.
Standard electron microscopy processing techniques were used for negative staining. Briefly, formvar coated, 200 mesh nickel grids were prepared. Grids, sample side down were floated on droplets of suspended poliovirus, followed by fixation in a solution of 1% glutaraldehyde in 0.1 M phosphate buffered saline (PBS), pH 7.4. Samples were washed in PBS, then in water followed by phosphotungstic acid. The samples were viewed with a F. E. I. Tecnai 12 BioTwin electron microscope and digital images were captured with an ATM camera system. In each sample the viral particles were counted within a 20 mm2 area.
The following PV proteins with a C-terminal his tag were expressed in E. coli and purified by nickel column chromatography (Qiagen): 3CDpro(3CproH40A), a proteinase active site mutant ; 3Cpro(3CproC147G), a proteinase active site mutant . The purification of 3CDpro(3CproH40G, 3DpolR455A/R456A) was described previously . This protein contains both a proteinase active site mutation (3CproH40G) and a mutation (3DpolR455A/R456A) at interface I in the 3Dpol domain of the protein.
Poliovirus sequences were derived from plasmid pT7PVM, which contains the full-length (nt 1–7525) plus strand poliovirus cDNA sequence . All constructs were sequenced to ensure their accuracy. The construction of plasmids pLOP315ser and pLOP315(3CproR84S/I86A) was described before [8, 9]. Both plasmid DNAs were linearized with EcoRI prior to transcription with T7 RNA polymerase.
We are grateful to D. W. Kim for his help in the preparation of HeLa cell-free extracts and for helpful discussions. We thank R. Andino for the plasmid containing PV1(M) cDNA preceded by a hammer-head ribozyme, prib(+)XPA and S. Van Horn for the electron microscopic analyses. This work was supported by two grants from the National Institute of Allergy and Infectious Diseases (E. Wimmer, R37 AI015122-30; and C. Cameron AI053531).
- Molla A, Paul AV, Wimmer E: Cell-free de novo synthesis of poliovirus. Science 1991,254(5038):1647-1651.View ArticlePubMedGoogle Scholar
- Barton DJ, Flanegan JB: Synchronous replication of poliovirus RNA: initiation of negative-strand RNA synthesis requires the guanidine-inhibited activity of protein 2C. J Virol 1997,71(11):8482-8489.PubMed CentralPubMedGoogle Scholar
- Fogg MH, Teterina NL, Ehrenfeld E: Membrane requirements for uridylylation of the poliovirus VPg protein and viral RNA synthesis in vitro. J Virol 2003,77(21):11408-11416. 10.1128/JVI.77.21.11408-11416.2003PubMed CentralView ArticlePubMedGoogle Scholar
- Murray KE, Barton DJ: Poliovirus CRE-dependent VPg uridylylation is required for positive-strand RNA synthesis but not for negative-strand RNA synthesis. J Virol 2003,77(8):4739-4750. 10.1128/JVI.77.8.4739-4750.2003PubMed CentralView ArticlePubMedGoogle Scholar
- Molla A, Paul AV, Wimmer E: Effects of temperature and lipophilic agents on poliovirus formation and RNA synthesis in a cell-free system. J Virol 1993,67(10):5932-5938.PubMed CentralPubMedGoogle Scholar
- Towner JS, Mazanet MM, Semler BL: Rescue of defective poliovirus RNA replication by 3AB-containing precursor polyproteins. J Virol 1998,72(9):7191-7200.PubMed CentralPubMedGoogle Scholar
- Wimmer E, Hellen CUT, Cao X: Genetics of poliovirus. Annu Rev Genet 1993, 27: 353-436. 10.1146/annurev.ge.27.120193.002033View ArticlePubMedGoogle Scholar
- Franco D, Pathak HB, Cameron CE, Rombaut B, Wimmer E, Paul AV: Stimulation of poliovirus synthesis in a HeLa cell-free in vitro translation-RNA replication system by viral protein 3CD pro . J Virol 2005,79(10):6358-6367. 10.1128/JVI.79.10.6358-6367.2005PubMed CentralView ArticlePubMedGoogle Scholar
- Verlinden Y, Cuconati A, Wimmer E, Rombaut B: The viral protein 3CD induces an equilibrium between the viral protein and RNA synthesis in a cell-free system for poliovirus replication. Arch Virol 2002,147(4):731-744. 10.1007/s007050200022View ArticlePubMedGoogle Scholar
- Paul AV: Possible unifying mechanism of picornavirus genome replication. In Molecular biology of picornaviruses. Edited by: Semler BL, Wimmer E. ASM press:Washington, DC; 2002:227-246.View ArticleGoogle Scholar
- Rossman MG: Picornavirus structure overview. In Molecular biology of picornaviruses. Edited by: Semler BL, Wimmer E. ASM press:Washington, DC; 2002.Google Scholar
- Verlinden Y, Cuconati A, Wimmer E, Rombaut B: Cell-free synthesis of poliovirus: 14S subunits are the key intermediates in the encapsidation of poliovirus RNA. J Gen Virol 2000,81(11):2751-2754.View ArticlePubMedGoogle Scholar
- Nugent CI, Kirkegaard K: RNA binding properties of poliovirus subviral particles. J Virol 1995,69(1):13-22.PubMed CentralPubMedGoogle Scholar
- Vance LM, Moscufo N, Chow M, Heinz BA: Poliovirus 2C region functions during encapsidation of viral RNA. J Virol 1997,71(11):8759-8765.PubMed CentralPubMedGoogle Scholar
- Reuer Q, Kuhn RJ, Wimmer E: Characterization of poliovirus clones containing lethal and nonlethal mutations in the genome-linked protein VPg. J Virol 1990,64(6):2967-2975.PubMed CentralPubMedGoogle Scholar
- Ypma-Wong MF, Dewalt PG, Johnson VH, Lamb JG, Semler BL: Protein 3CD is the major poliovirus proteinase responsible for cleavage of the P1 capsid precursor. Virology 1988,166(1):265-270. 10.1016/0042-6822(88)90172-9View ArticlePubMedGoogle Scholar
- Andino R, Rieckhof E, Achacoso PL, Baltimore D: Poliovirus RNA synthesis utilizes an RNP complex formed around the 5'-end of viral RNA. EMBO J 1993,12(9):3587-3598.PubMed CentralPubMedGoogle Scholar
- Gamarnik AV, Andino R: Interactions of viral protein 3CD and poly(rC) binding protein with the 5' nontranslated region of the poliovirus genome. J Virol 2000,74(5):2219-2226. 10.1128/JVI.74.5.2219-2226.2000PubMed CentralView ArticlePubMedGoogle Scholar
- Harris K, Xiang W, Alexander L, Lane WS, Paul AV, Wimmer E: Interaction of the poliovirus polypeptide 3CD pro with the 5' and 3' termini of the poliovirus genome: identification of viral and cellular factors cofactors needed for binding. J Biol Chem 1994,269(43):27004-27014.PubMedGoogle Scholar
- Paul AV, Rieder E, Kim DW, van Boom JH, Wimmer E: Identification of an RNA hairpin in poliovirus RNA that serves as the primary template for the uridylylation of VPg in vitro. J Virol 2000,74(22):10359-10370. 10.1128/JVI.74.22.10359-10370.2000PubMed CentralView ArticlePubMedGoogle Scholar
- Yin J, Paul AV, Wimmer E, Rieder E: Functional dissection of a poliovirus cis -acting replication element [PV- cre (2C)]: analysis of single- and dual- cre viral genomes and proteins that bind specifically to PV- cre RNA. J Virol 2003,77(9):5152-5166. 10.1128/JVI.77.9.5152-5166.2003PubMed CentralView ArticlePubMedGoogle Scholar
- Parsley TB, Towner JS, Blyn LB, Ehrenfeld E, Semler BL: Poly(rC)binding protein 2 forms a ternary complex with the 5'-terminal sequences of poliovirus RNA and the viral 3CD proteinase. RNA 1997,3(10):1124-1134.PubMed CentralPubMedGoogle Scholar
- Gamarnik AV, Andino R: Switch from translation to RNA replication in a positive strand RNA virus. Genes Dev 1998,12(15):2293-2304.PubMed CentralView ArticlePubMedGoogle Scholar
- Herold J, Andino R: Poliovirus RNA replication requires genome circularization through a protein bridge. Mol Cell 2001,7(3):581-591. 10.1016/S1097-2765(01)00205-2View ArticlePubMedGoogle Scholar
- Blair WS, Parsley TB, Bogerd HP, Towner JS, Semler BL, Cullen BR: Utilization of a mammalian cell-based RNA binding assay to characterize the RNA binding properties of picornavirus 3C proteinases. RNA 1998,4(2):215-225.PubMed CentralPubMedGoogle Scholar
- Hammerle T, Molla A, Wimmer E: Mutational analysis of the proposed FG loop of poliovirus proteinase 3C identifies amino acids that are necessary for 3CD cleavage and might be determinants of a function distinct from proteolytic activity. J Virol 1992,66(10):6028-6034.PubMed CentralPubMedGoogle Scholar
- Cornell CT, Semler BL: Subdomain specific functions of the RNA polymerase region of poliovirus 3CD polypeptide. Virology 2002,298(2):200-213. 10.1006/viro.2002.1481View ArticlePubMedGoogle Scholar
- Parsley TB, Cornell CT, Semler BL: Modulation of the RNA binding and protein processing activities of poliovirus polypeptide 3CD by the viral RNA polymerase domain. J Biol Chem 1999,274(18):12867-12876. 10.1074/jbc.274.18.12867View ArticlePubMedGoogle Scholar
- Flanegan JB, Baltimore D: Poliovirus-specific primer-dependent RNA polymerase able to copy poly(A). Proc Natl Acad Sci USA 1977,74(9):3677-3680.PubMed CentralView ArticlePubMedGoogle Scholar
- Thompson AA, Peersen OB: Structural basis for proteolysis-dependent activation of the poliovirus RNA-dependent RNA polymerase. EMBO J 2004,23(17):3462-3471. 10.1038/sj.emboj.7600357PubMed CentralView ArticlePubMedGoogle Scholar
- Pata JD, Schultz SC, Kirkegaard K: Functional oligomerization of poliovirus RNA dependent RNA polymerase. RNA 1995,1(5):466-477.PubMed CentralPubMedGoogle Scholar
- Diamond SE, Kirkegaard K: Clustered charged-to-alanine mutagenesis of poliovirus RNA-dependent RNA polymerase yields multiple temperature sensitive mutants defective in RNA synthesis. J Virol 1994,68(2):863-876.PubMed CentralPubMedGoogle Scholar
- Pathak HB, Ghosh SKB, Roberts AW, Sharma SD, Yoder JD, Arnold JJ, Gohara DW, Barton DJ, Paul AV, Cameron CE: Structure-function relationships of the RNA-dependent RNA polymerase from poliovirus (3D pol ). A surface of the primary oligomerization domain functions in capsid precursor processing and VPg uridylylation. J Biol Chem 2002,277(35):31551-31562. 10.1074/jbc.M204408200View ArticlePubMedGoogle Scholar
- Barton DJ, Black EP, Flanegan JB: Complete replication of poliovirus in vitro: preinitiation RNA replication complexes require soluble cellular factors for the synthesis of VPg-linked RNA. J Virol 1995,69(9):5516-5527.PubMed CentralPubMedGoogle Scholar
- Takeda N, Kuhn RJ, Yang CF, Takegami T, Wimmer E: Initiation of poliovirus plus-strand RNA synthesis in a membrane complex of infected HeLa cells. J Virol 1986,60(1):43-53.PubMed CentralPubMedGoogle Scholar
- Lee MW, Wang W: Human rhinovirus type 16: Mutant V1210A requires capsid-binding drug for assembly of pentamers to form virions during morphogenesis. J Virol 2003,77(11):6235-6244. 10.1128/JVI.77.11.6235-6244.2003PubMed CentralView ArticlePubMedGoogle Scholar
- Fernandez-Tomas CB, Baltimore D: Morphogenesis of poliovirus. II. Demonstration of a new intermediate, the provirion. J Virol 1973,12(5):1122-1130.PubMed CentralPubMedGoogle Scholar
- van der Werf S, Bradley J, Wimmer E, Studier FW, Dunn JJ: Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase. Proc Natl Acad Sci USA 1986,83(8):2330-2334.PubMed CentralView ArticlePubMedGoogle Scholar
- Herold J, Andino R: Poliovirus requires a precise 5' end for efficient positive-strand RNA synthesis. J Virol 2000,74(14):6394-6400. 10.1128/JVI.74.14.6394-6400.2000PubMed CentralView ArticlePubMedGoogle Scholar
- Teterina NL, Rinaudo MS, Ehrenfeld E: Strand-specific RNA synthesis defects in a poliovirus with a mutation in 3A. J Virol 2003,77(23):12679-12691. 10.1128/JVI.77.23.12679-12691.2003PubMed CentralView ArticlePubMedGoogle Scholar
- Teterina NL, Zhou WD, Cho MW, Ehrenfeld E: Inefficient complementation activity of poliovirus 2C and 3D proteins for rescue of lethal mutations. J Virol 1995,69(7):4245-4254.PubMed CentralPubMedGoogle Scholar
- Egger D, Teterina N, Ehrenfeld E, Bienz K: Formation of the poliovirus replication complex requires coupled viral translation, vesicle production and viral RNA synthesis. J Virol 2000,74(14):6570-6580. 10.1128/JVI.74.14.6570-6580.2000PubMed CentralView ArticlePubMedGoogle Scholar
- Novak JE, Kirkegaard K: Coupling between genome translation and replication in an RNA virus. Genes and Dev 1994,8(14):1726-1737.View ArticlePubMedGoogle Scholar
- Xiang W, Harris KS, Alexander L, Wimmer E: Interaction between the 5'-terminal cloverleaf and 3AB/3CD pro of poliovirus is essential for RNA replication. J Virol 1995,69(6):3658-3667.PubMed CentralPubMedGoogle Scholar
- Rieder E, Paul AV, Kim DW, Van Boom JH, Wimmer E: Genetic and biochemical studies of poliovirus cis -acting replication element cre in relation to VPg uridylylation. J Virol 2000,74(22):10371-10380. 10.1128/JVI.74.22.10371-10380.2000PubMed CentralView ArticlePubMedGoogle Scholar
- Lyons T, Murray KE, Roberts AW, Barton DJ: Poliovirus 5'-terminal cloverleaf RNA is required in cis for VPg uridylylation and the initiation of negative-strand RNA synthesis. J Virol 2001,75(22):10696-10708. 10.1128/JVI.75.22.10696-10708.2001PubMed CentralView ArticlePubMedGoogle Scholar
- Walter BL, Parsley TB, Ehrenfeld E, Semler BL: Distinct poly(rC) binding protein KH domain determinants for poliovirus translation initation and viral RNA replication. J Virol 2002,76(23):12008-12022. 10.1128/JVI.76.23.12008-12022.2002PubMed CentralView ArticlePubMedGoogle Scholar
- Mosimann SC, Cherney MM, Sia S, Plotch S, James MNG: Refined X-ray crystallographic structure of the poliovirus 3C gene product. J Mol Biol 1997,273(5):1032-1047. 10.1006/jmbi.1997.1306View ArticlePubMedGoogle Scholar
- Basavappa R, Syed R, Flore O, Icenogle JP, Filman DJ, Hogle JM: Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: Structure of the empty capsid assembly intermediate at 2.9 A resolution. Protein Science 1994,3(10):1651-1669.PubMed CentralView ArticlePubMedGoogle Scholar
- Cornell CT, Brunner JE, Semler BL: Differential rescue of poliovirus RNA replication functions by genetically modified RNA polymerase precursors. J Virol 2004,78(23):13007-13018. 10.1128/JVI.78.23.13007-13018.2004PubMed CentralView ArticlePubMedGoogle Scholar
- Xiang W, Cuconati A, Hope D, Kirkegaard K, Wimmer E: Complete protein linkage map of poliovirus P3 proteins: interaction of polymerase 3D pol with VPg and with genetic variants of 3AB. J Virol 1998,72(8):6732-6741.PubMed CentralPubMedGoogle Scholar
- Newman JFE, Brown F: Foot-and-Mouth disease virus and poliovirus particles contain proteins of the replication complex. J Virol 1997,71(10):7657-7662.PubMed CentralPubMedGoogle Scholar
- Ambros V, Baltimore D: Protein is linked to the 5' end of poliovirus RNA by a phophodiester linkage to tyrosine. J Biol Chem 1978,253(15):5263-5266.PubMedGoogle Scholar
- Nomoto A, Kitamura N, Golini F, Wimmer E: The 5'terminal structures of poliovirion RNA and poliovirus mRNA differ only in the genome-linked protein. Proc Natl Acad Sci USA 1977,74(12):5345-5349.PubMed CentralView ArticlePubMedGoogle Scholar
- Lu HH, Yang CF, Murdin AD, Klein MH, Harber JJ, Kew OM, Wimmer E: Mouse neurovirulence determinants of poliovirus type 1 strain LS-a map to the coding regions of capsid protein VP1 and proteinase 2A pro . J Virol 1994,68(11):7507-7515.PubMed CentralPubMedGoogle Scholar
- Cuconati A, Molla A, Wimmer E: Brefeldin A inhibits cell-free, de novo synthesis of poliovirus. J Virol 1998,72(8):6456-6464.PubMed CentralPubMedGoogle Scholar
- Paul AV, Rieder E, Kim DW, van Boom JH, Wimmer E: Identification of an RNA hairpin in poliovirus RNA that serves as the primary template for the uridylylation of VPg in vitro. J Virol 2000,74(22):10359-10370. 10.1128/JVI.74.22.10359-10370.2000PubMed CentralView ArticlePubMedGoogle Scholar
- Pfister T, Jones KW, Wimmer E: A cysteine-rich motif in poliovirus protein 2C ATPase is involved in RNA replication and binds zinc in vitro. J Virol 2000,74(1):334-343.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.